News | Blog

ACNE & KELOID SCARS

The efficacy of a nanofat and plasma rich-platlets injection and fractional CO2 laser resurfacing was evaluated in 30 patients
Read More

SKIN REVITALISATION 

In this case series of 23 patients, the authors evaluated if there are real outcomes, benefits and side effects following a standardised PRP...
Read More

NEW COLLAGEN 

In this prospective controlled clinical study, the authors evaluated the efficacy of an intradermal injection of RegenPRP for human facial...
Read More

Dubai Derma 2025

Visit us at Stand 7E11, Dubai World Trade Center, from 14th to 16th April to discover our latest innovations in regenerative medicine.Let’s connect...
Read More

EWMA-GNEAUPP 2025

We are delighted to announce that Regen Lab will be participating in the 35th Conference of the European Wound Management Association (EWMA), taking...
Read More

AMWC 2025

Visit us Hall Ravel Booth N8 and discover how our regenerative solutions are transforming aesthetics and anti-ageing medicine.Let’s connect at our...
Read More

Nordic Partnership

We are thrilled to announce the beginning of a new era in the distribution of Regen Lab products across Sweden, Norway, and Denmark. This exciting...
Read More

BeNeLux Partnership

We are pleased to announce an exciting development for Regen Lab in the BeNeLux region. To enhance our presence and ensure optimal service, we have...
Read More

IMCAS World 2025

Visit us at L205 and discover how our regenerative solutions are transforming aesthetics and anti-ageing medicine.Let’s connect at our booth to...
Read More

Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufa​cturing of high-quality medical devices, intended for cells therapies.

CONTACT US

Discover innovative regenerative medicine solutions with Regen Lab – contact us today to elevate your treatments and enhance patient care!

Copyright © 2025 All rights reserved.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.